Inclusion Criteria:  Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and availability for the duration of the study Female, aged 18-40 Willingness to refrain from ibuprofen or naproxen sodium (such as Advil, Aleve, Motrin or Midol) during each period (pill bleed) during the study Ability to take oral medication and be willing to adhere to the dietary supplement regimen Use of hormonal contraception for at least 3 months prior to screening and agreement to use such a method during study participation. Hormonal contraception must allow for pill bleeds to occur. Moderate self-reported discomfort during menstruation related to bloating, pelvic cramps, fatigue or mood swings. On a scale of 1-10, participants must report at least a 4 on two or more symptoms. Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration  Exclusion Criteria:  Current use of GnRH agonists and antagonists including Lupron or Orilissa Current use of an extended activity hormonal contraception (for example, Depo-provera or Nexplanon) Current use of hyperthyroid medication such as methimazole Current use of blood thinning medication Pregnancy, lactation, or attempting to become pregnant during study Known allergic reactions to components of the dietary supplement (sunflower oil, ashwagandha, curcumin, resveratrol, Boswellia, milk thistle, quercetin or catechins)